Abstract
The progression of neurological abnormalities through four or five clinically distinguishable levels of deepening coma and the development of a fatty liver are the hallmarks of Reye syndrome. A number of animal models have been described that result in fatty liver formation with minimal, static, or catastrophic neurological changes. In this study, we attempted to produce neurological features in rabbits that reflected a rostral-caudal progression of abnormalities that could be categorized into clinically distinguishable levels reminiscent of Reye syndrome. This was accomplished by the intracisternal administration of 0.5-25 mg of 11,14-icosadienoic acid (20:2 omega 6) suspended in a mixture of rabbit serum and isotonic saline solution. A reproducible, dose-titratable spectrum of at least four levels of deepening coma could be produced at will. Increases in serum glutamate-oxaloacetate transaminase and creatine kinase and changes in serum glucose resulted 1-2 hr after the neurological abnormalities were evoked. Other unsaturated fatty acids produced similar responses. Those tested included 18:1 omega 9, 18:2 omega 6, 18:3 omega 3, 20:3 omega 6, 20:4 omega 6, and 22:4 omega 6 fatty acids. Saturated fatty acids, including 6:0, 8:0, 16:0, 18:0, and 20:0, failed to elicit these effects. The abnormalities were sustained for 30-120 min after a single dose. Full recovery was observed in some animals that had not reached the fourth level of our grading system for coma. Pretreatment of the rabbits with aspirin modulated the neurological abnormalities. Twenty micrograms of bee venom melittin, which activates endogenous phospholipase A2, administered intracisternally into rabbits also produced signs of level 3 (our grading system) coma for several hours. These findings suggest a possible role for polyunsaturated fatty acids in the development of Reye syndrome and offer a means of producing the neurological components of that syndrome in a laboratory animal.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alvira M. M., Forman D. T. Biochemical abnormalities in Reye's syndrome. Ann Clin Lab Sci. 1974 Nov-Dec;4(6):477–483. [PubMed] [Google Scholar]
- Bobo R. C., Schubert W. K., Partin J. C., Partin J. S. Reye syndrome: treatment by exchange transfusion with special reference to the 1974 epidemic in Cincinnati, Ohio. J Pediatr. 1975 Dec;87(6 Pt 1):881–886. doi: 10.1016/s0022-3476(75)80898-5. [DOI] [PubMed] [Google Scholar]
- Brightman M. W., Hori M., Rapoport S. I., Reese T. S., Westergaard E. Osmotic opening of tight junctions in cerebral endothelium. J Comp Neurol. 1973 Dec 15;152(4):317–325. doi: 10.1002/cne.901520402. [DOI] [PubMed] [Google Scholar]
- Chan P. H., Fishman R. A. Brain edema: induction in cortical slices by polyunsaturated fatty acids. Science. 1978 Jul 28;201(4353):358–360. doi: 10.1126/science.663662. [DOI] [PubMed] [Google Scholar]
- Chan P. H., Fishman R. A., Caronna J., Schmidley J. W., Prioleau G., Lee J. Induction of brain edema following intracerebral injection of arachidonic acid. Ann Neurol. 1983 Jun;13(6):625–632. doi: 10.1002/ana.410130608. [DOI] [PubMed] [Google Scholar]
- Chaves-Carballo E., Ellefson R. D. Tissue lipids in hyperammonemic encephalopathies of childhood. Arch Neurol. 1980 Mar;37(3):165–167. doi: 10.1001/archneur.1980.00500520063011. [DOI] [PubMed] [Google Scholar]
- Colon A. R., Ledesma F., Pardo V., Sandberg D. H. Viral potentiation of chemical toxins in the experimental syndrome of hypoglycemia, encephalopathy, and visceral fatty degeneration. Am J Dig Dis. 1974 Dec;19(12):1091–1101. doi: 10.1007/BF01076143. [DOI] [PubMed] [Google Scholar]
- Corey L., Rubin R. J., Bregman D., Gregg M. B. Diagnostic criteria for influenza B-associated Reye's syndrome: clinical vs. pathologic criteria. Pediatrics. 1977 Nov;60(5):702–708. [PubMed] [Google Scholar]
- Crocker J. F., Rozee K. R., Ozere R. L., Digout S. C., Hutzinger O. Insecticide and viral interaction as a cause of fatty visceral changes and encephalopathy in the mouse. Lancet. 1974 Jul 6;2(7871):22–24. doi: 10.1016/s0140-6736(74)91351-8. [DOI] [PubMed] [Google Scholar]
- Deshmukh D. R., Maassab H. F., Mason M. Interactions of aspirin and other potential etiologic factors in an animal model of Reye syndrome. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7557–7560. doi: 10.1073/pnas.79.23.7557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dhopeshwarkar G. A., Subramanian C., McConnell D. H., Mead J. F. Fatty acid transport into the brain. Biochim Biophys Acta. 1972 Feb 11;255(2):572–579. doi: 10.1016/0005-2736(72)90161-7. [DOI] [PubMed] [Google Scholar]
- Fishman R. A. Brain edema. N Engl J Med. 1975 Oct 2;293(14):706–711. doi: 10.1056/NEJM197510022931407. [DOI] [PubMed] [Google Scholar]
- Gilman S., Van der Meulen J. P. Cryogenic decerebration. Arch Neurol. 1965 Sep;13(3):297–306. doi: 10.1001/archneur.1965.00470030077007. [DOI] [PubMed] [Google Scholar]
- Glasgow A. M., Chase H. P. Production of the features of Reye's syndrome in rats with 4-pentenoic acid. Pediatr Res. 1975 Mar;9(3):133–138. doi: 10.1203/00006450-197503000-00005. [DOI] [PubMed] [Google Scholar]
- Haymond M. W., Karl I. E., Keating J. P., DeVivo D. C. Metabolic response to hypertonic glucose administration in Reye syndrome. Ann Neurol. 1978 Mar;3(3):207–215. doi: 10.1002/ana.410030305. [DOI] [PubMed] [Google Scholar]
- Henle G., Henle W. NEUROLOGICAL SIGNS IN MICE FOLLOWING INTRACEREBRAL INOCULATION OF INFLUENZA VIRUSES. Science. 1944 Nov 3;100(2601):410–411. doi: 10.1126/science.100.2601.410. [DOI] [PubMed] [Google Scholar]
- Hochberg F. H., Nelson K., Janzen W. Influenza type B-related encephalopathy. The 1971 outbreak of Reye syndrome in Chicago. JAMA. 1975 Feb 24;231(8):817–821. doi: 10.1001/jama.231.8.817. [DOI] [PubMed] [Google Scholar]
- Hug G., Bosken J., Bove K., Linnemann C. C., Jr, McAdams L. Reye's syndrome simulacra in liver of mice after treatment with chemical agents and encephalomyocarditis virus. Lab Invest. 1981 Jul;45(1):89–109. [PubMed] [Google Scholar]
- Huttenlocher P. R. Reye's syndrome: relation of outcome to therapy. J Pediatr. 1972 May;80(5):845–850. doi: 10.1016/s0022-3476(72)80145-8. [DOI] [PubMed] [Google Scholar]
- Kang E. S., Gates R. E., Wrenn E. L., Jr Abnormal cellular regulation of lipolysis and phosphorylation in Reye's Syndrome. Biochem Med. 1982 Apr;27(2):180–194. doi: 10.1016/0006-2944(82)90020-5. [DOI] [PubMed] [Google Scholar]
- Kang E. S., Schwenzer K. S., Wall H. P., Jabbour J. T., Shade R., Crofton J. T., Share L. Urea, altered renal function, and vasopressin in Reye-Johnson syndrome. Biochem Med. 1982 Feb;27(1):121–134. doi: 10.1016/0006-2944(82)90014-x. [DOI] [PubMed] [Google Scholar]
- Koeppen A. H., Barron K. D., Mitzen E. J. Phospholipids, fatty acids and fatty aldehydes in rat brain subcellular fractions. Brain Res. 1971 Dec 10;35(1):199–214. doi: 10.1016/0006-8993(71)90605-6. [DOI] [PubMed] [Google Scholar]
- Lichtenstein P. K., Heubi J. E., Daugherty C. C., Farrell M. K., Sokol R. J., Rothbaum R. J., Suchy F. J., Balistreri W. F. Grade I Reye's syndrome. A frequent cause of vomiting and liver dysfunction after varicella and upper-respiratory-tract infection. N Engl J Med. 1983 Jul 21;309(3):133–139. doi: 10.1056/NEJM198307213090302. [DOI] [PubMed] [Google Scholar]
- Linnemann C. C., Jr, Shea L., Kauffman C. A., Schiff G. M., Partin J. C., Schubert W. K. Association of Reye's syndrome with viral infection. Lancet. 1974 Jul 27;2(7874):179–182. doi: 10.1016/s0140-6736(74)91481-0. [DOI] [PubMed] [Google Scholar]
- Linnemann C. C., Jr, Shea L., Partin J. C., Schubert W. K., Schiff G. M. Reye's syndrome: epidemiologic and viral studies, 1963-1974. Am J Epidemiol. 1975 Jun;101(6):517–526. doi: 10.1093/oxfordjournals.aje.a112123. [DOI] [PubMed] [Google Scholar]
- Lovejoy F. H., Jr, Smith A. L., Bresnan M. J., Wood J. N., Victor D. I., Adams P. C. Clinical staging in Reye syndrome. Am J Dis Child. 1974 Jul;128(1):36–41. doi: 10.1001/archpedi.1974.02110260038007. [DOI] [PubMed] [Google Scholar]
- MOHRHAUER H., HOLMAN R. T. ALTERATION OF THE FATTY ACID COMPOSITION OF BRAIN LIPIDS BY VARYING LEVELS OF DIETARY ESSENTIAL FATTY ACIDS. J Neurochem. 1963 Jul;10:523–530. doi: 10.1111/j.1471-4159.1963.tb09855.x. [DOI] [PubMed] [Google Scholar]
- Ogburn P. L., Jr, Sharp H., Lloyd-Still J. D., Johnson S. B., Holman R. T. Abnormal polyunsaturated fatty acid patterns of serum lipids in Reye's syndrome. Proc Natl Acad Sci U S A. 1982 Feb;79(3):908–911. doi: 10.1073/pnas.79.3.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- REYE R. D., MORGAN G., BARAL J. ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA. A DISEASE ENTITY IN CHILDHOOD. Lancet. 1963 Oct 12;2(7311):749–752. doi: 10.1016/s0140-6736(63)90554-3. [DOI] [PubMed] [Google Scholar]
- Rapoport S. I. Osmotic opening of the blood-brain barrier. Ciba Found Symp. 1978 Mar;(56):237–255. doi: 10.1002/9780470720370.ch13. [DOI] [PubMed] [Google Scholar]
- Sinclair A. J. Long-chain polyunsaturated fatty acids in the mammalian brain. Proc Nutr Soc. 1975 Dec;34(3):287–291. doi: 10.1079/pns19750051. [DOI] [PubMed] [Google Scholar]
- Trauner D. A., Adams H. Intracranial pressure elevations during octanoate infusion in rabbits: an experimental model of Reye's syndrome. Pediatr Res. 1981 Aug;15(8):1097–1099. doi: 10.1203/00006450-198108000-00005. [DOI] [PubMed] [Google Scholar]




